Robotic technology in cardiovascular medicine

被引:60
|
作者
Bonatti, Johannes [1 ]
Vetrovec, George [2 ]
Riga, Celia [3 ]
Wazni, Oussama [4 ]
Stadler, Petr [5 ]
机构
[1] Cleveland Clin Abu Dhabi, Inst Heart & Vasc, Abu Dhabi, U Arab Emirates
[2] Virginia Commonwealth Univ, Pauley Heart Ctr, Med Coll Virginia, Richmond, VA 23298 USA
[3] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Div Surg, Reg Vasc Unit, London W2 1NY, England
[4] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44195 USA
[5] Na Homolce Hosp, Dept Vasc Surg, Prague 15030 5, Czech Republic
关键词
CORONARY-ARTERY-BYPASS; EPICARDIAL LEAD IMPLANTATION; ENDOVASCULAR ANEURYSM REPAIR; REMOTE-CONTROL SYSTEM; SEPTAL-DEFECT REPAIR; CATHETER ABLATION; CARDIAC-SURGERY; SAFETY; NAVIGATION; FEASIBILITY;
D O I
10.1038/nrcardio.2014.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Robotic technology has been used in cardiovascular medicine since the late 1990s. Interventional cardiology, electrophysiology, endovascular surgery, minimally invasive cardiac surgery, and laparoscopic vascular surgery are all fields of application. Robotic devices enable endoscopic reconstructive surgery in narrow spaces and fast, very precise placement of catheters and devices in catheter-based interventions. In all robotic systems, the operator manipulates the robotic arms from a control station or console. In the field of cardiac surgery, mitral valve repair, CABG surgery, atrial septal defect repair, and myxoma resection can be achieved using robotic technology. Furthermore, vascular surgeons can perform a variety of robotically assisted operations to treat aortic, visceral, and peripheral artery disease. In electrophysiology, ablation procedures for atrial fibrillation can be carried out with robotic support. In the past few years, robotically assisted percutaneous coronary intervention and abdominal aortic endovascular surgery techniques have been developed. The basic feasibility and safety of robotic approaches in cardiovascular medicine has been demonstrated, but learning curves and the high costs associated with this technology have limited its widespread use. Nonetheless, increased procedural speed, accuracy, and reduced exposure to radiation and contrast agent in robotically assisted catheter-based interventions, as well as reduced surgical trauma and shortened patient recovery times after robotic cardiovascular surgery are promising achievements in the field.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
  • [41] PRODRUGS IN CARDIOVASCULAR MEDICINE
    THIJSSEN, HHW
    DRIEMAN, HC
    CARDIOVASCULAR DRUG REVIEWS, 1990, 8 (04): : 386 - 400
  • [42] Biomarkers in Cardiovascular Medicine
    Martin-Ventura, Jose L.
    Blanco-Colio, Luis M.
    Tunon, Jose
    Munoz-Garcia, Begona
    Madrigal-Matute, Julio
    Moreno, Juan A.
    Vega de Ceniga, Melina
    Egido, Jesus
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (06): : 677 - 688
  • [43] Evidence in cardiovascular medicine
    Hampton, JR
    PRACTITIONER, 1999, 243 (1603) : 718 - +
  • [44] Cardiovascular intensive medicine
    Strauer, B
    Werdan, K
    INTERNIST, 2005, 46 (03): : 247 - 247
  • [45] Exosomes in Cardiovascular Medicine
    Dykes I.M.
    Cardiology and Therapy, 2017, 6 (2) : 225 - 237
  • [46] Pharmacogenetics in Cardiovascular Medicine
    Sony Tuteja
    Nita Limdi
    Current Genetic Medicine Reports, 2016, 4 (3) : 119 - 129
  • [47] Interdisciplinary cardiovascular medicine
    Deng, MC
    MEDIZINISCHE WELT, 1998, 49 (01): : 1 - 5
  • [48] Semaphorins in cardiovascular medicine
    Cora, Davide
    Astanina, Elena
    Giraudo, Enrico
    Bussolino, Federico
    TRENDS IN MOLECULAR MEDICINE, 2014, 20 (10) : 589 - 598
  • [49] Photonics in cardiovascular medicine
    Gijs van Soest
    Evelyn Regar
    Antonius F. W. van der Steen
    Nature Photonics, 2015, 9 : 626 - 629
  • [50] Rapamycin in cardiovascular medicine
    Ruygrok, PN
    Muller, DW
    Serruys, PW
    INTERNAL MEDICINE JOURNAL, 2003, 33 (03) : 103 - 109